Brainshake Closes €3.5M to Advance Regulatory Approval of Blood Analysis Service
HELSINKI, 14 SEP 2016, PRESS RELEASEFinnish Brainshake has raised 3.5 million euros in Series A funding. The investment will be used to advance regulatory approval and internationalization of its blood analysis service. Brainshake’s blood analysis service provides more than 220 biomarkers from a single blood sample – 50 times more than commonly used laboratory methods. Biomarkers reflect the health state of an individual and can be used to predict disease risk in chronic diseases. Brainshake’s blood analysis, backed up by 100 peer-reviewed scientific publications, is used by leading